Colossal's $10B valuation is massively undervalued

Colossal's $10B valuation is massively undervalued | it's massively undervalued. I I totally agree with you.

it's massively undervalued. I I totally agree with you.

Beneficiaries (23)

Adverse (4)

{
  "nia": false,
  "qty": "Current $10B valuation is undervalued",
  "url": "https://www.youtube.com/watch?v=Goa6c6Qz__I",
  "mode": "THESIS",
  "role": "Guest-CEO",
  "context": "You build a company which goes from zero to $10 billion valuation in 4 years. >> It it's massively undervalued. I I totally agree with you.",
  "verbatim": "it's massively undervalued. I I totally agree with you.",
  "conv_cues": "massively undervalued; totally agree",
  "direction": "UP",
  "timeframe": "Present",
  "conv_level": "HIGH",
  "milestones": [
    {
      "kind": "llm_pre_event",
      "label": "Colossal closes Series C extension at $10.3B valuation",
      "notes": "HIT — base valuation Lamm called undervalued.",
      "source": "https://techstartups.com/2025/09/17/biotech-startup-colossal-biosciences-raises-120m-to-revive-the-dodo-bird-and-other-extinct-species-hits-10-3b-valuation/ — $120M tranche to $10.3B valuation",
      "status": "hit",
      "weight": 0.4,
      "ordinal": -7,
      "source_id": null,
      "confidence": 0.99,
      "source_url": "https://techstartups.com/2025/09/17/biotech-startup-colossal-biosciences-raises-120m-to-revive-the-dodo-bird-and-other-extinct-species-hits-10-3b-valuation/",
      "expected_date": "2025-09-17",
      "observed_date": "2025-09-17",
      "research_origin": "deep_research",
      "measurement_criterion": "Colossal Biosciences raises additional Series C tranche bringing valuation to $10.3B (decacorn status)"
    },
    {
      "kind": "quartile_checkpoint",
      "label": "Q1 window check-in (25%)",
      "status": "pending",
      "weight": 0.05,
      "ordinal": -6,
      "source_id": null,
      "expected_date": "2026-09-23",
      "observed_date": null
    },
    {
      "kind": "llm_pre_event",
      "label": "Colossal announces first viable mammoth embryo",
      "source": "https://www.jpost.com/science/science-around-the-world/article-838315 — first embryos targeted late 2026",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -5,
      "source_id": null,
      "confidence": 0.55,
      "source_url": "https://www.jpost.com/science/science-around-the-world/article-838315",
      "expected_date": "2027-01-30",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2027-06-30",
        "from": "2026-09-01"
      },
      "measurement_criterion": "Colossal publicly announces first successfully transferred or viable woolly-mammoth embryo (mammoth-elephant hybrid)"
    },
    {
      "kind": "quartile_checkpoint",
      "label": "Q2 window check-in (50%)",
      "status": "pending",
      "weight": 0.05,
      "ordinal": -4,
      "source_id": null,
      "expected_date": "2027-02-17",
      "observed_date": null
    },
    {
      "kind": "llm_pre_event",
      "label": "Colossal raises follow-on round at >=$15B valuation (50% step-up)",
      "source": "https://pitchbook.com/profiles/company/481220-47 — Colossal funding history and valuation trajectory",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -3,
      "source_id": null,
      "confidence": 0.45,
      "source_url": "https://pitchbook.com/profiles/company/481220-47",
      "expected_date": "2027-03-17",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2027-12-31",
        "from": "2026-06-01"
      },
      "measurement_criterion": "Colossal closes Series D or strategic round at post-money valuation >=$15B, validating Lamm's 'massively undervalued' claim with new market mark"
    },
    {
      "kind": "quartile_checkpoint",
      "label": "Q3 window check-in (75%)",
      "status": "pending",
      "weight": 0.05,
      "ordinal": -2,
      "source_id": null,
      "expected_date": "2027-07-14",
      "observed_date": null
    },
    {
      "kind": "llm_post_event",
      "label": "First Colossal commercial spinout (Form Bio, Breaking) reaches >=$5B",
      "notes": "Spinout monetization is the key path that would valid
... (truncated)